Accelerating Neurology Availity Integration for Prior Authorization

Klivira streamlines **neurology Availity integration**, automating prior authorizations for complex treatments and diagnostics to improve operational efficiency and patient access.

Neurology practices face a high volume of prior authorizations for specialty drugs, advanced imaging, and procedures, often compounded by payer-specific rules. Navigating these requirements through multi-payer portals like Availity Essentials consumes significant administrative resources, diverting staff from patient care. Klivira addresses this by automating the PA workflow, ensuring compliance with clinical guidelines and payer policies.

The Challenge of Prior Authorizations in Neurology

Neurology encompasses conditions requiring complex, high-cost treatments and diagnostics, leading to a substantial prior authorization burden. From MS disease-modifying therapies (DMTs) and CGRP migraine biologics to advanced imaging and neurosurgical procedures, each often requires specific documentation aligned with AAN Practice Guidelines and payer medical policies. This complexity, coupled with frequent re-authorizations for chronic conditions, strains administrative teams.

High-Volume Neurology PA Triggers

**MS Disease-Modifying Therapies (DMTs):** Ocrelizumab, ofatumumab, natalizumab, and various oral DMTs often require extensive step therapy documentation.
**Alzheimer's Disease Therapeutics:** Anti-amyloid antibodies like lecanemab and donanemab demand specific amyloid confirmation (PET or CSF) and APOE genotyping.
**Migraine Prevention Biologics:** CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) and oral gepants frequently face step therapy requirements.
**Botox for Chronic Migraine/Spasticity:** OnabotulinumtoxinA and other neurotoxins require documentation of prior treatment failures and specific indication criteria.
**Advanced Imaging:** Brain MRI, MR angiography, and amyloid PET scans for diagnostic confirmation are common PA triggers.
**Neuromodulation:** Deep Brain Stimulation (DBS) and Vagus Nerve Stimulation (VNS) procedures necessitate detailed clinical justification and prior therapy trials.

Leveraging Availity Essentials for Neurology PA Submissions

Availity Essentials functions as a critical multi-payer clearinghouse, providing a centralized platform for submitting prior authorization requests to numerous commercial payers. For neurology practices, this means a single point of entry for many high-volume PA categories, reducing the need to navigate disparate payer portals. Klivira's integration with Availity streamlines the submission process, ensuring that neurology-specific documentation is accurately transmitted, often leveraging the X12 278 transaction standard for electronic prior authorization (ePA).

Klivira's Approach to Neurology Availity Integration

Klivira enhances the **neurology Availity integration** workflow by automating the collection and submission of clinical data directly from the EMR. Our platform applies AAN-guideline-aware step-therapy logic for MS DMTs and CGRP migraine prevention, ensuring that documentation for prior treatment trials is complete. For Alzheimer's anti-amyloid therapies, Klivira automates the inclusion of diagnostic biomarker confirmations, such as amyloid PET or CSF results, and MRI screening protocols, which are crucial for approval.

Operational Benefits for Neurology Practices

**Automated Documentation:** Clinical data for MS DMTs (McDonald criteria, EDSS, relapse history) and CGRP biologics (migraine days, prior failures) is automatically populated for Availity submissions.
**Biomarker Confirmation:** Streamlined inclusion of amyloid confirmation and APOE genotyping for Alzheimer's anti-amyloid antibody PAs.
**Step Therapy Compliance:** Proactive tracking of required prior oral preventive trials for CGRP migraine biologics and moderate-efficacy DMTs for MS.
**Re-authorization Management:** Automated workflows for periodic re-authorization of chronic neurology treatments, including ongoing MRI monitoring requirements.
**Reduced Denial Rates:** Minimizing common denial reasons such as incomplete step therapy, missing biomarker data, or gaps in chronic migraine criteria for Botox.

Seamless EMR Integration for Neurology Workflows

Klivira's EMR-agnostic platform integrates directly with your existing electronic medical record system, pulling relevant clinical notes, diagnostic reports, and medication histories. This eliminates manual data entry for neurology prior authorizations submitted via Availity, ensuring consistency and accuracy. By leveraging standards like SMART on FHIR, Klivira connects the clinical workflow directly to the payer authorization process, reducing administrative burden and accelerating patient access to critical neurology care.

Frequently asked questions

How does Klivira handle specific neurology drugs requiring PA via Availity?

Klivira's platform is configured with specific logic for high-volume neurology drugs. For MS DMTs, it tracks step therapy; for Alzheimer's anti-amyloid antibodies, it automates biomarker documentation; and for CGRP migraine biologics, it ensures prior preventive trial failures are documented, all for seamless submission through Availity.

What EMR systems does Klivira integrate with for neurology Availity submissions?

Klivira offers EMR-agnostic integration capabilities, leveraging standards like SMART on FHIR. This allows us to connect with a wide range of EMR systems, pulling necessary clinical data directly to populate prior authorization requests for submission via Availity, regardless of your specific EMR vendor.

Can Klivira help with re-authorizations for chronic neurology treatments?

Yes, Klivira automates the workflow for periodic re-authorization of chronic neurology treatments, such as MS DMTs and certain epilepsy specialty drugs. Our system tracks re-authorization deadlines and prompts for necessary updated clinical documentation, including ongoing MRI monitoring results, before submitting to payers via Availity.

How does Klivira ensure compliance with AAN guidelines for neurology PAs submitted via Availity?

Klivira incorporates AAN-guideline-aware logic into its automation engine. This means our platform guides the collection of required documentation, such as McDonald criteria for MS, amyloid confirmation for AD, and specific criteria for Botox, ensuring that all submissions through Availity align with established clinical guidelines and payer medical policies.

What types of payers are accessible through Availity for neurology PAs?

Availity Essentials serves as a multi-payer clearinghouse, providing access to most major commercial payers. This means neurology practices can submit prior authorization requests for a broad spectrum of health plans through a single portal, which Klivira's integration further streamlines.